Skip to content

Medical-device intelligence

OBP: Transcranial Magnetic Stimulator

FDA product code OBP: Transcranial Magnetic Stimulator. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
OBP
FDA device name
Transcranial Magnetic Stimulator
Device class
2
Regulation number
882.5805
Medical specialty
Neurology
Review panel
NE

FDA definition

A transcranial magnetic stimulator is a device that delivers brief duration, rapidly alternating, or pulsed, magnetic fields to induce electrical currents that are directed at spatially discrete regions of the cerebral cortex for the treatment of major depressive disorder.
Explore neurology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

68 clearance records and 6 recall records in the covered releases, across 21 source company names and 1 product codes. Dated history runs from Dec 16, 2008 to Sep 6, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202510
December 202500
January 202600
February 202610
March 202620
April 202600
May 202620
June 202600
July 202600
August 202621
September 202610
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
OBP · Transcranial Magnetic Stimulator686

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

74 matching records
Device / recordCompany in FDA recordSourceSource date
ZapStim Controller Application (Z1023)K233631 · OBPRevital Lab, Inc.510(k)Feb 9, 2024FDA decision date
NQ TMS for MDD (NQv1-MU-01)K232688 · OBPNeuroqore, Inc.510(k)Dec 29, 2023FDA decision date
NeuroStar Advanced Therapy System (Version 3.8)K233621 · OBPNeuronetics510(k)Dec 13, 2023FDA decision date
Magstim®Horizon® 3.0 TMS Therapy System; Horizon® 3.0 System; Horizon® 3.0; Horizon® 3.0 with Navigation; Horizon® 3.0 with StimGuide ProK232235 · OBPThe Magstim Company , Ltd.510(k)Oct 25, 2023FDA decision date
Ultimate rTMS; Yingchi rTMSK230735 · OBPBrain Ultimate, Inc.510(k)Sep 13, 2023FDA decision date
NeuroStar Advanced Therapy System (Version 3.7)K230029 · OBPNeuronetics510(k)Apr 4, 2023FDA decision date
Magstim Horizon 3.0 TMS Therapy System, Horizon 3.0 System, Horizon 3.0, H3.0, Horizon 3.0 with StimGuide+K223154 · OBPMagstim Company, Ltd.510(k)Mar 16, 2023FDA decision date
Magstim Horizon 3.0 TMS Therapy System, Horizon 3.0 System, Horizon 3.0, H3.0, Horizon 3.0 with StimGuide+K222171 · OBPMagstim Company, Ltd.510(k)Jan 13, 2023FDA decision date
Magnus Neuromodulation System (MNS) with SAINT Technology, Model Number 1001KK220177 · OBPMagnus Medical, Inc.510(k)Sep 1, 2022FDA decision date
BrainsWay Deep TMS SystemK220819 · OBPBrainsway , Ltd.510(k)Aug 26, 2022FDA decision date
NeuroStar, NeuroStar TMS Therapy System, NeuroStar Advanced Therapy System, NeuroStar Advanced Therapy System for Mental HealthK222230 · OBPNeuronetics, Inc.510(k)Aug 24, 2022FDA decision date
NeuroStar TMS Therapy System, NeuroStar Advanced Therapy System, NeuroStar, NeuroStar Advanced Therapy for Mental HealthK220127 · OBPNeuronetics, Inc.510(k)Jul 15, 2022FDA decision date
ALTMS Magnetic Stimulation Therapy System, Blossom TMS Therapy SystemK220625 · OBPRemed Co., Ltd.510(k)Apr 6, 2022FDA decision date
BTL-995-rTMSK212723 · OBPBTL Industries, Inc.510(k)Mar 4, 2022FDA decision date
NeuroStar TMS Therapy System, NeuroStar Advanced Therapy System, NeuroStar, NeuroStar Advanced Therapy for Mental HealthK213543 · OBPNeuronetics, Inc.510(k)Dec 10, 2021FDA decision date
ALTMS Magnetic Stimulation Therapy SystemK202537 · OBPRemed Co., Ltd.510(k)Nov 26, 2021FDA decision date
Magstim Horizon 3.0 TMS Therapy System, Horizon 3.0 System, Horizon 3.0, Horizon 3.0 with NavigationK211389 · OBPMagstim Company, Ltd.510(k)Sep 14, 2021FDA decision date
Deep Transcranial Magnetic Stimulation (DTMS) SystemK210201 · OBPBrainsway , Ltd.510(k)Aug 17, 2021FDA decision date
Brainsway Deep TMS SystemK203735 · OBPBrainsway , Ltd.510(k)Apr 23, 2021FDA decision date
NeuroStar Advanced TherapyK201158 · OBPNeuronetics, Inc.510(k)Nov 20, 2020FDA decision date
Horizon PSU Stim Interconnecting Cable - Product Usage: Horizon is indicated for the treatment of Major Depressive Disorder in adult patients who…Z-1965-2020 · OBPThe Magstim Company LimitedRecallMay 13, 2020FDA record creation date
Rapid2 PSU Stim Interconnecting Cable - Product Usage: indicated for the treatment of Major Depressive Disorder in adult patients who have fail…Z-1966-2020 · OBPThe Magstim Company LimitedRecallMay 13, 2020FDA record creation date
HORIZON TMS Therapy System with NavigationK183376 · OBPMagstim Company, Ltd.510(k)Apr 3, 2019FDA decision date
Nexstim Navigated Brain Therapy (NBT) System 2K182700 · OBPNexstim Plc510(k)Mar 22, 2019FDA decision date
HORIZON TMS Therapy SystemK182853 · OBPMagstim Company, Ltd.510(k)Mar 15, 2019FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗